Please Wait...

SCOPE Summit for Clinical Trials Operations Executive

SCOPE Summit for Clinical Trials Operations Executive
February 23, 2016 - 1:00am (EST) to February 25, 2016 - 1:00am (EST)

Miami, FL

Booth #404

Bioclinica will introduce its latest offering, Post-Approval Research, at the 7th Annual SCOPE Summit. Nayan Nanavati, COO, Bioclinica Post-Approval Research, will give a presentation entitled, "It's Time to Rethink How Post-Approval Studies Are Done" on Wednesday, February 24 from 9:45-10:10 am.

On Tuesday, February 23 at 12:05, be sure to catch Ron Burns, Vice President, Product Management, eHealth Solutions in his session, "Integrating Mobile Application Generated Patient Data into your Risk-Based Monitoring Strategy." In this session Ron will talk about how innovative patient-centered mobile applications - from the newest biosensors to complete digital health records - are connecting patients with physicians and other health providers. Integrating this data into your clinical applications, such as the patient diary in your EDC system or as alerts in your Risk-based Monitoring application, now offers new horizons in patient safety and trial quality. Don't miss this opportunity to learn what's happening on this front.

Visit Booth #404 to learn more or to request a one-on-one meeting or demonstration.

SCOPE offers three stimulating days of in-depth discussions in 12 different conferences focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Forecasting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, and Pharmacovigilance.

Visit event website

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

[Fun Friday] Now that's using you noodle! Ck this out in @RandDMagazine https://t.co/o5h9O1ScBF
bioclinica (7 hours ago)
FDA, NIH & Industry Advance Templates for Clinical Trial Protocols | RAPS https://t.co/Cqda7fLQZf
bioclinica (Yesterday)
Significant Safety Events Found in a Third of FDA-Approved Drugs, Study Finds | RAPS https://t.co/mAHe42W4or
bioclinica (Yesterday)
FDA Official Highlights Foreign Supply Chain Challenges | RAPS https://t.co/qHDtoRw9MS
bioclinica (Yesterday)
RT @MySCRS: Survey finds 50% of Americans are unaware of #ClinicalTrials, reported by @EdClinical. https://t.co/57x8gtXRT0
bioclinica (Yesterday)
RT @ACROhealth: Recent poll data from @ResearchAmerica, 59% of those polled said their family’s health has been improved by clinical resear…
bioclinica (Yesterday)

Latest Blogs: